Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Tremfya rescues J&J’s immunology sales to fuel strong Q3
Despite several products succumbing to generics and biosimilars, J&J raised its 2026 guidance.
Read Full Article
Express Pharma
NuSynth to build chemical process innovation platform with new capital
The company will use the capital to develop its R&D and technology capabilities, proprietary processes, scale-up capabilities and team The post NuSynth to build chemical process innovation platform with new capital appeared first on Express Pharma.
Read Full Article
Express Pharma
Dermatology meets aesthetics: Why the boundary between skin health and cosmetic care is changing
The relationship between dermatology and aesthetic medicine is one of the most compelling issues in recent years. Dermatology has always concerned itself with the diagnosis and treatment of skin diseases, […] The post Dermatology meets aesthetics: Why the boundary between skin health and cosmetic care is changing appeared first on Express Pharma.
Read Full Article
Express Pharma
India’s biotech growth story is now a manufacturing story: G Balaji
As production becomes more complex and highly regulated, digitalisation and automation are emerging as critical enablers. G Balaji, SVP, Energy Industries, ABB India in an exclusive interview with Swati Rana discusses how Pharma 4.0, connected manufacturing and integrated plant infrastructure can help India’s biotech sector translate scientific innovation into commercially viable production The post India’s biotech growth story is now a manufacturing story: G Balaji appeared first on Express Pharma.
Read Full Article
Pharma Tech
Roche bets on the RNAi approach for obesity through $1bn Rona deal
Roche now joins a growing list of big pharma and biotech players exploring the RNAi approach’s promise in treating obesity.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Oct 13, 2026, 2:34 PM
Tremfya rescues J&J’s immunology sales to fuel strong Q3
Despite several products succumbing to generics and biosimilars, J&J raised its 2026 guidance.
ET Pharma
Oct 13, 2026, 1:14 PM
Roche strikes obesity drug licensing deal worth up to $1.16 bln with Chinese Rona Therapeutics
With the deal, Rona Therapeutics is set to receive an upfront payment of $100 million and is eligible to receive up to $1.06 billion in potential milestone payments, as well as tiered royalties on global net sales.
PharmaShots
Oct 13, 2026, 1:00 PM
The US FDA New Drug Approvals in September 2026
Shots: Ionis’ Zanvastro (Zilganersen) Receives US FDA Approval for Alexander Disease (AxD) Company: Ionis Product: Zanvastro Active Ingredient: Zilganersen Disease: Alexander Disease Date: Sep 03, 2026 Shots: Editor’s Take: Beyond the Headlines Zanvastro’s FDA approval gives Ionis a first-mover position in Alexander disease, establishing a targeted treatment option for a rare, underserved population. The approval… The post The US FDA New Drug Approvals in September 2026 appeared first on PharmaShots.
PharmaShots
Oct 13, 2026, 12:30 PM
Ambry Genetics Launches GenomeNext and GenomeReveal for Rare Disease Diagnosis
Shots: Ref: Businesswire | Image: Ambry Genetics | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Ambry Genetics Launches GenomeNext and GenomeReveal for Rare Disease Diagnosis appeared first on PharmaShots.
PharmaShots
Oct 13, 2026, 11:30 AM
Zydus and Formycon Report the US FDA BLA Acceptance for FYB206 (Biosimilar, Keytruda)
Shots: Ref: Zydus | Image: Zydus & Formycon | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Zydus and Formycon Report the US FDA BLA Acceptance for FYB206 (Biosimilar, Keytruda) appeared first on PharmaShots.
Express Pharma
Oct 13, 2026, 11:04 AM
NuSynth to build chemical process innovation platform with new capital
The company will use the capital to develop its R&D and technology capabilities, proprietary processes, scale-up capabilities and team The post NuSynth to build chemical process innovation platform with new capital appeared first on Express Pharma.
News
Latest industry coverage
Google News
Oct 13, 2026, 9:15 PM
Remember ‘Pharma Bro?’ He’s still at it, feds and states allege. - Crain's Chicago Business
Remember ‘Pharma Bro?’ He’s still at it, feds and states allege. Crain's Chicago Business
Google News
Oct 13, 2026, 8:59 PM
Pharmaceutical Scientists Rally Around Particle Engineering as Drug Delivery Hits a Translational Crossroads - Bioengineer.org
Pharmaceutical Scientists Rally Around Particle Engineering as Drug Delivery Hits a Translational Crossroads Bioengineer.org
Google News
Oct 13, 2026, 8:46 PM
ForgeStop and EM Microelectronic Win CPHI Pharma Award 2026 for Secure Connected Packaging - The National Law Review
ForgeStop and EM Microelectronic Win CPHI Pharma Award 2026 for Secure Connected Packaging The National Law Review
Google News
Oct 13, 2026, 8:46 PM
MIT Lincoln Lab Hosts National Security Biotech Commission - Mirage News
MIT Lincoln Lab Hosts National Security Biotech Commission Mirage News
Google News
Oct 13, 2026, 8:45 PM
California accuses 'Pharma Bro' of violating pharmaceutical industry ban - Visalia Times-Delta
California accuses 'Pharma Bro' of violating pharmaceutical industry ban Visalia Times-Delta
Google News
Oct 13, 2026, 8:44 PM
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion - Reuters
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion Reuters
Google News
Oct 13, 2026, 8:32 PM
Pharma Payments And Gifts Influence Doctors’ Prescribing Practices, Review Concludes - Word & Brown General Agency
Pharma Payments And Gifts Influence Doctors’ Prescribing Practices, Review Concludes Word & Brown General Agency
Google News
Oct 13, 2026, 8:22 PM
‘Pharma Bro’ Martin Shkreli has caught the attention of federal and state authorities again - News Channel 3-12
‘Pharma Bro’ Martin Shkreli has caught the attention of federal and state authorities again News Channel 3-12
Google News
Oct 13, 2026, 8:15 PM
FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks - WSJ
FTC, States Ask Court to Hold ‘Pharma Bro’ Shkreli in Contempt for Trading Drug Stocks WSJ
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer